Nancy Duarte-Lonnroth
Keine laufenden Positionen mehr
Karriereverlauf von Nancy Duarte-Lonnroth
Ehemalige bekannte Positionen von Nancy Duarte-Lonnroth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACER THERAPEUTICS INC. | Corporate Officer/Principal | 01.05.2018 | - |
| CELESTICA INC. | General Counsel | 04.02.2010 | - |
| Corporate Officer/Principal | 18.03.2013 | 20.03.2013 |
Ausbildung von Nancy Duarte-Lonnroth
| University of Massachusetts | Graduate Degree |
| Franklin Pierce University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Electronic Technology | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CELESTICA INC. | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Börse
- Insiders
- Nancy Duarte-Lonnroth
- Erfahrung